Diabetes complications

RenoTrue: A diabetes-specific machine learning model to estimate glomerular filtration rate for people with diabetes

Diabetes Res Clin PractPublished Diagnostic accuracy study

Authors' conclusion

For people with diabetes, RenoTrue demonstrated better performance compared to the 2009 CKD-EPI equation in terms of estimating GFR across the full range of GFR.

Study context

Population
People with T1D and T2D from five international cohorts; median mGFR 75 ml/min per 1.73 m², median age 59 yearstest dataset 20%
Participants
5,619 people
Comparison
RenoTrue vs 2009 CKD-EPI equation, against mGFR
Outcome
Performance vs mGFR in test dataset (agreement, bias, p30)
Methodological detailsmachine learning model development and validation, five international cohorts, training/validation/test split
  • Machine learning model development and validation
  • Five international cohorts
  • Training/validation/test split

Performance

As reported in the abstract

Test or modelICCBias (ml/min per 1.73 m²)p30
RenoTrue0.87 (95% CI: 0.78, 0.93)−0.57 (95% CI: −1.59, 0.46)81% (95% CI: 79%, 83%)
2009 CKD-EPI0.86 (95% CI: 0.77, 0.92)4.17 (95% CI: 3.14, 5.20)74% (95% CI: 72%, 77%)

ICC

RenoTrue0.87 (95% CI: 0.78, 0.93)
2009 CKD-EPI0.86 (95% CI: 0.77, 0.92)

Bias (ml/min per 1.73 m²)

RenoTrue−0.57 (95% CI: −1.59, 0.46)
2009 CKD-EPI4.17 (95% CI: 3.14, 5.20)

p30

RenoTrue81% (95% CI: 79%, 83%)
2009 CKD-EPI74% (95% CI: 72%, 77%)

Original publication

RenoTrue: A diabetes-specific machine learning model to estimate glomerular filtration rate for people with diabetes. Diabetes Res Clin Pract. Published 2 February 2026. doi:10.1016/j.diabres.2026.113137

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.